SCR-LIP-000568 · Claim · machine-readable JSON →
In a retrospective evaluation of 46 women with lipedema, the disease was associated with painful fat refractory to lifestyle change, gait and joint abnormalities, fatigue (~75%), hypermobility (>50%), lymphedema, and psychosocial distress, documenting functional and mobility impairment.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Lipedema: Friend and Foe (2018) ✓ verified — consistent · case series · 2018 · reading confidence: high
“Lipedema is a foe because lifestyle change does not reduce lipedema fat, the fat is painful, can become obese, causes gait and joint abnormalities, fatigue, lymphedema and psychosocial distress.”
The article explicitly documents gait and joint abnormalities, fatigue, hypermobility exacerbating joint disease, and psychosocial impairment as negative ('foe') aspects of lipedema, directly affirming functional disability and mobility lim
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000040
- 2026-11-20 — consolidated · SQ-LIP-000040: evidence moved to SCR-LIP-000776